1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ventilator Associated Pneumonia (VAP) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Prevention 1.2.3 Physiotherapy 1.2.4 Immunity Therapy 1.3 Market by Application 1.3.1 Global Ventilator Associated Pneumonia (VAP) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 ASCs 1.3.4 Diagnostic Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ventilator Associated Pneumonia (VAP) Market Perspective (2016-2027) 2.2 Ventilator Associated Pneumonia (VAP) Growth Trends by Regions 2.2.1 Ventilator Associated Pneumonia (VAP) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Ventilator Associated Pneumonia (VAP) Historic Market Share by Regions (2016-2021) 2.2.3 Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Regions (2022-2027) 2.3 Ventilator Associated Pneumonia (VAP) Industry Dynamic 2.3.1 Ventilator Associated Pneumonia (VAP) Market Trends 2.3.2 Ventilator Associated Pneumonia (VAP) Market Drivers 2.3.3 Ventilator Associated Pneumonia (VAP) Market Challenges 2.3.4 Ventilator Associated Pneumonia (VAP) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ventilator Associated Pneumonia (VAP) Players by Revenue 3.1.1 Global Top Ventilator Associated Pneumonia (VAP) Players by Revenue (2016-2021) 3.1.2 Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Players (2016-2021) 3.2 Global Ventilator Associated Pneumonia (VAP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ventilator Associated Pneumonia (VAP) Revenue 3.4 Global Ventilator Associated Pneumonia (VAP) Market Concentration Ratio 3.4.1 Global Ventilator Associated Pneumonia (VAP) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ventilator Associated Pneumonia (VAP) Revenue in 2020 3.5 Ventilator Associated Pneumonia (VAP) Key Players Head office and Area Served 3.6 Key Players Ventilator Associated Pneumonia (VAP) Product Solution and Service 3.7 Date of Enter into Ventilator Associated Pneumonia (VAP) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ventilator Associated Pneumonia (VAP) Breakdown Data by Type 4.1 Global Ventilator Associated Pneumonia (VAP) Historic Market Size by Type (2016-2021) 4.2 Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Type (2022-2027) 5 Ventilator Associated Pneumonia (VAP) Breakdown Data by Application 5.1 Global Ventilator Associated Pneumonia (VAP) Historic Market Size by Application (2016-2021) 5.2 Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Ventilator Associated Pneumonia (VAP) Market Size (2016-2027) 6.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Type 6.2.1 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) 6.2.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) 6.2.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027) 6.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Application 6.3.1 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) 6.3.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) 6.3.3 North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027) 6.4 North America Ventilator Associated Pneumonia (VAP) Market Size by Country 6.4.1 North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) 6.4.2 North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Ventilator Associated Pneumonia (VAP) Market Size (2016-2027) 7.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type 7.2.1 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) 7.2.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) 7.2.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027) 7.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application 7.3.1 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) 7.3.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) 7.3.3 Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027) 7.4 Europe Ventilator Associated Pneumonia (VAP) Market Size by Country 7.4.1 Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) 7.4.2 Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size (2016-2027) 8.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type 8.2.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027) 8.3 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application 8.3.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027) 8.4 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region 8.4.1 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size (2016-2027) 9.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type 9.2.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) 9.2.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) 9.2.3 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027) 9.3 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application 9.3.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) 9.3.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) 9.3.3 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027) 9.4 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country 9.4.1 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) 9.4.2 Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size (2016-2027) 10.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type 10.2.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2027) 10.3 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application 10.3.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2027) 10.4 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country 10.4.1 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Philips Respironics 11.1.1 Philips Respironics Company Details 11.1.2 Philips Respironics Business Overview 11.1.3 Philips Respironics Ventilator Associated Pneumonia (VAP) Introduction 11.1.4 Philips Respironics Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.1.5 Philips Respironics Recent Development 11.2 Hoffrichter 11.2.1 Hoffrichter Company Details 11.2.2 Hoffrichter Business Overview 11.2.3 Hoffrichter Ventilator Associated Pneumonia (VAP) Introduction 11.2.4 Hoffrichter Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.2.5 Hoffrichter Recent Development 11.3 Johnson Controls 11.3.1 Johnson Controls Company Details 11.3.2 Johnson Controls Business Overview 11.3.3 Johnson Controls Ventilator Associated Pneumonia (VAP) Introduction 11.3.4 Johnson Controls Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.3.5 Johnson Controls Recent Development 11.4 Teleflex 11.4.1 Teleflex Company Details 11.4.2 Teleflex Business Overview 11.4.3 Teleflex Ventilator Associated Pneumonia (VAP) Introduction 11.4.4 Teleflex Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.4.5 Teleflex Recent Development 11.5 Weinmann 11.5.1 Weinmann Company Details 11.5.2 Weinmann Business Overview 11.5.3 Weinmann Ventilator Associated Pneumonia (VAP) Introduction 11.5.4 Weinmann Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.5.5 Weinmann Recent Development 11.6 ResMed 11.6.1 ResMed Company Details 11.6.2 ResMed Business Overview 11.6.3 ResMed Ventilator Associated Pneumonia (VAP) Introduction 11.6.4 ResMed Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.6.5 ResMed Recent Development 11.7 SYSMED 11.7.1 SYSMED Company Details 11.7.2 SYSMED Business Overview 11.7.3 SYSMED Ventilator Associated Pneumonia (VAP) Introduction 11.7.4 SYSMED Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.7.5 SYSMED Recent Development 11.8 Fisher & Paykel 11.8.1 Fisher & Paykel Company Details 11.8.2 Fisher & Paykel Business Overview 11.8.3 Fisher & Paykel Ventilator Associated Pneumonia (VAP) Introduction 11.8.4 Fisher & Paykel Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) 11.8.5 Fisher & Paykel Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ventilator Associated Pneumonia (VAP) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Prevention Table 3. Key Players of Physiotherapy Table 4. Key Players of Immunity Therapy Table 5. Global Ventilator Associated Pneumonia (VAP) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Ventilator Associated Pneumonia (VAP) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Ventilator Associated Pneumonia (VAP) Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2016-2021) Table 9. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2022-2027) Table 11. Ventilator Associated Pneumonia (VAP) Market Trends Table 12. Ventilator Associated Pneumonia (VAP) Market Drivers Table 13. Ventilator Associated Pneumonia (VAP) Market Challenges Table 14. Ventilator Associated Pneumonia (VAP) Market Restraints Table 15. Global Ventilator Associated Pneumonia (VAP) Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Ventilator Associated Pneumonia (VAP) Market Share by Players (2016-2021) Table 17. Global Top Ventilator Associated Pneumonia (VAP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ventilator Associated Pneumonia (VAP) as of 2020) Table 18. Ranking of Global Top Ventilator Associated Pneumonia (VAP) Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Ventilator Associated Pneumonia (VAP) Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Ventilator Associated Pneumonia (VAP) Product Solution and Service Table 22. Date of Enter into Ventilator Associated Pneumonia (VAP) Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million) Table 25. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2016-2021) Table 26. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Ventilator Associated Pneumonia (VAP) Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Application (2016-2021) Table 30. Global Ventilator Associated Pneumonia (VAP) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million) Table 33. North America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million) Table 35. North America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size by Country (2022-2027) & (US$ Million) Table 62. Philips Respironics Company Details Table 63. Philips Respironics Business Overview Table 64. Philips Respironics Ventilator Associated Pneumonia (VAP) Product Table 65. Philips Respironics Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 66. Philips Respironics Recent Development Table 67. Hoffrichter Company Details Table 68. Hoffrichter Business Overview Table 69. Hoffrichter Ventilator Associated Pneumonia (VAP) Product Table 70. Hoffrichter Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 71. Hoffrichter Recent Development Table 72. Johnson Controls Company Details Table 73. Johnson Controls Business Overview Table 74. Johnson Controls Ventilator Associated Pneumonia (VAP) Product Table 75. Johnson Controls Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 76. Johnson Controls Recent Development Table 77. Teleflex Company Details Table 78. Teleflex Business Overview Table 79. Teleflex Ventilator Associated Pneumonia (VAP) Product Table 80. Teleflex Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 81. Teleflex Recent Development Table 82. Weinmann Company Details Table 83. Weinmann Business Overview Table 84. Weinmann Ventilator Associated Pneumonia (VAP) Product Table 85. Weinmann Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 86. Weinmann Recent Development Table 87. ResMed Company Details Table 88. ResMed Business Overview Table 89. ResMed Ventilator Associated Pneumonia (VAP) Product Table 90. ResMed Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 91. ResMed Recent Development Table 92. SYSMED Company Details Table 93. SYSMED Business Overview Table 94. SYSMED Ventilator Associated Pneumonia (VAP) Product Table 95. SYSMED Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 96. SYSMED Recent Development Table 97. Fisher & Paykel Company Details Table 98. Fisher & Paykel Business Overview Table 99. Fisher & Paykel Revenue in Ventilator Associated Pneumonia (VAP) Business (2016-2021) & (US$ Million) Table 100. Fisher & Paykel Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Ventilator Associated Pneumonia (VAP) Market Share by Type: 2020 VS 2027 Figure 2. Prevention Features Figure 3. Physiotherapy Features Figure 4. Immunity Therapy Features Figure 5. Global Ventilator Associated Pneumonia (VAP) Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. ASCs Case Studies Figure 8. Diagnostic Centers Case Studies Figure 9. Ventilator Associated Pneumonia (VAP) Report Years Considered Figure 10. Global Ventilator Associated Pneumonia (VAP) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Ventilator Associated Pneumonia (VAP) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions: 2020 VS 2027 Figure 13. Global Ventilator Associated Pneumonia (VAP) Market Share by Regions (2022-2027) Figure 14. Global Ventilator Associated Pneumonia (VAP) Market Share by Players in 2020 Figure 15. Global Top Ventilator Associated Pneumonia (VAP) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ventilator Associated Pneumonia (VAP) as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Ventilator Associated Pneumonia (VAP) Revenue in 2020 Figure 17. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2016-2021) Figure 18. Global Ventilator Associated Pneumonia (VAP) Revenue Market Share by Type (2022-2027) Figure 19. North America Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027) Figure 21. North America Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027) Figure 22. North America Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027) Figure 23. United States Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027) Figure 27. Europe Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027) Figure 28. Europe Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027) Figure 29. Germany Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027) Figure 37. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027) Figure 38. Asia-Pacific Ventilator Associated Pneumonia (VAP) Market Share by Region (2016-2027) Figure 39. China Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027) Figure 47. Latin America Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027) Figure 48. Latin America Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027) Figure 49. Mexico Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Share by Type (2016-2027) Figure 53. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Share by Application (2016-2027) Figure 54. Middle East & Africa Ventilator Associated Pneumonia (VAP) Market Share by Country (2016-2027) Figure 55. Turkey Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Ventilator Associated Pneumonia (VAP) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Philips Respironics Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 59. Hoffrichter Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 60. Johnson Controls Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 61. Teleflex Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 62. Weinmann Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 63. ResMed Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 64. SYSMED Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 65. Fisher & Paykel Revenue Growth Rate in Ventilator Associated Pneumonia (VAP) Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Philips Respironics Hoffrichter Johnson Controls Teleflex Weinmann ResMed SYSMED Fisher & Paykel